首页> 外文期刊>The pharmaceutical journal >What can Europe learn from the British experience of POM-to-P switching?
【24h】

What can Europe learn from the British experience of POM-to-P switching?

机译:欧洲可以从英国从POM到P切换的经验中学到什么?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PROBABLY every pharmacist in the UK has a friend who came back from holiday with stories about how they were able to buy loads of prescription medicines while they were abroad, even antibiotics. Despite anything you may say, they will be convinced that other countries have more over-the-counter products than the UK does. However, that simply is not the case. Nonprescription medicines in most EU countries are still limited to products for indications that are short-term, such as headache or indigestion, where doctors would treat without a formal diagnosis, at least in the first instance. Furthermore, the range of products looks old fashioned compared with what is available in the UK.
机译:大概英国的每个药剂师都有一个朋友,他从假期回来时讲了关于他们如何能够在国外购买大量处方药,甚至抗生素的故事。不管您说什么,他们都会说服其他国家比英国拥有更多的非处方产品。但是,事实并非如此。在大多数欧盟国家,非处方药仍仅限于短期适应症的产品,例如头痛或消化不良,至少在最初情况下,医生会在未经正式诊断的情况下进行治疗。此外,与英国的产品相比,该产品系列看起来过时了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号